Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

ClinicalTrials.gov ID: NCT04057573

Public ClinicalTrials.gov record NCT04057573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 9:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

Study identification

NCT ID
NCT04057573
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
344 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2019 (Actual)
Primary completion
Mar 15, 2021 (Actual)
Completion
Oct 1, 2021 (Actual)
Last update posted
Aug 22, 2025

2019 – 2021

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Desert Sky Dermatology Gilbert Arizona 85295 —
Center For Dermatology Cosmetic and Laser Surgery Fremont California 94538 —
Uci Beckman Laser Institute and Medical Clinic Irvine California 92617 —
UCI Health Beckman Laser Institute and Medical Center Irvine California 92697 —
Vitiligo & Pigmentation Institute of Southern California Los Angeles California 90036 —
Dermatology Research Associates Los Angeles California 90045 —
Dermatology Specialists Inc Murrieta California 92562 —
Dermatology Specialists Inc Oceanside California 92056 —
Integrative Skin Science and Research Sacramento California 95815 —
Acrc Studies San Diego California 92119 —
Central Sooner Research San Diego California 92123 —
Colorado Medical Research Center Inc Denver Colorado 80210 —
Advanced Pharma Cr Miami Florida 33147 —
Leavitt Medical Associates of Florida Ormond Beach Florida 32174 —
Avita Clinical Research Tampa Florida 33613 —
Olympian Clinical Research Tampa Florida 33614 —
Ashira Dermatology Llc Gurnee Illinois 60031 —
Randall Dermatology of West Lafayette West Lafayette Indiana 47096 —
Randall Dermatology West Lafayette Indiana 47906 —
Delricht Clinical Research - Clinedge - Ppds Baton Rouge Baton Rouge Louisiana 70809 —
Tufts Medical Center Boston Massachusetts 02111 —
Tufts Medical Center Boston Massachusetts 02116 —
Metro Boston Clinical Partners Brighton Massachusetts 02135 —
University of Massachusetts Worcester Massachusetts 01655 —
Henry Ford Hospital Detroit Michigan 48202 —
Henry Ford Medical Center Detroit Michigan 48202 —
Minnesota Clinical Study Center Minneapolis Minnesota 55432 —
Jdr Dermatology Research Las Vegas Nevada 89148 —
Northwell Physician Partners New Hyde Park New York 11042 —
Icahn School of Medicine At Mount Sinai New York New York 10029 —
Derm Research Center of New York Inc Stony Brook New York 11790 —
Central Sooner Research Norman Oklahoma 73071 —
Oregon Medical Research Center Portland Oregon 97223 —
Clinical Research Partners Llc Richmond Virginia 23220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04057573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2025 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04057573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →